Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00639418 · ClinicalTrials.gov registry record

A Study to Describe Pediatric Influenza Vaccine Coverage

A clinical trial, sponsored by MedImmune.

Completed
Registry status
147,494
Enrollment target

NCT00639418 is a clinical trial that has completed, run by MedImmune. The registered enrollment target is 147,494 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00639418 has completed, sponsored by MedImmune.

COMPLETED
Registry status
147,494 participants
Enrollment target

Study Summary

The purpose of this study is to describe flu vaccine coverage in children under 18 years of age and to examine correlations between in-office flu vaccine coverage and the use of various tactics to increase vaccine coverage.

Interventions

  • BIOLOGICAL Influenza vaccination

Trial Details

FieldValue
Enrollment Target 147,494 participants
Start Date 2007-08
Est. Completion 2011-06

Sponsor

MedImmune

210 total trials

What the Registry Record Tells You About NCT00639418

The ClinicalTrials.gov registry entry for NCT00639418 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 147,494 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Influenza vaccination is the first listed.

NCT00639418 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00639418 about?

NCT00639418 is a clinical study titled "A Study to Describe Pediatric Influenza Vaccine Coverage". The purpose of this study is to describe flu vaccine coverage in children under 18 years of age and to examine correlations between in-office flu vaccine coverage and the use of various tactics to increase vaccine coverage.

What is the current status of trial NCT00639418?

This trial is currently completed. The enrollment target is 147,494 participants. The study started on 2007-08. Estimated completion is 2011-06.

What interventions are being tested in trial NCT00639418?

The interventions under investigation include: Influenza vaccination (BIOLOGICAL).

Who is sponsoring clinical trial NCT00639418?

This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.